Tessera
Folgen

Ilias Goranitis

@iliasgoranitis.bsky.social

Head, Economics of Genomics & Precision Medicine Unit, University of Melbourne | Health Economics Lead, Australian Genomics | Deputy Head, Melbourne Health Economics, Centre for Health Policy #HealthEconomics #Genomics

20 Posts242 Follower139 Folgt
Nature Medicine@natmed.nature.com · 8mo ago

How can we measure the value of #genomics in #healthcare? How can #HTA, #implementation & data management be adapted to suit the rapidly evolving nature of genomics? For insights, read the Review from Zornitza Stark, Ilias Goranitis & colleagues. https://www.nature.com/articles/s41591-025-04061-3

Determining the value of genomics in healthcare - Nature Medicine

Assessing the value of genomics is key to informing evidence-based policies; this Review outlines how current approaches to health technology assessment, implementation and data management can be adapted to suit the rapidly evolving technology and evidence base.

nature.com

Ilias Goranitis@iliasgoranitis.bsky.social · 8mo ago

In this Nature Medicine paper, we draw from our experiences in evaluating and implementing #genomics in Australia, Canada, England, Hong Kong and the US www.nature.com/articles/s41...

Determining the value of genomics in healthcare - Nature Medicine

Assessing the value of genomics is key to informing evidence-based policies; this Review outlines how current approaches to health technology assessment, implementation and data management can be adap...

nature.com

Zornitza Stark@zornitza.bsky.social · 8mo ago

www.nature.com/articles/s41... 🔥🔥🔥 Is genomics value for money??? 🧬💰 👉 How do we define it? 👉 Measure it? 👉 And deliver it? rdcu.be/eR243 @iliasgoranitis.bsky.social @stephaniebest.bsky.social @hadleyssmith.bsky.social @rich-genomics.bsky.social @jbuchanan-ox.bsky.social @rdexeter.bsky.social

Determining the value of genomics in healthcare - Nature Medicine

Assessing the value of genomics is key to informing evidence-based policies; this Review outlines how current approaches to health technology assessment, implementation and data management can be adap...

nature.com

GenomeSeb@genomeseb.bsky.social · 10mo ago

Proud to share our BabyScreen+ #gNBS study is now out in @naturemedicine.bsky.social: 1000 babies screened, results in <2wks, 16 high chance findings, incl. 2 with major impact on care. Big thanks to @zornitza.bsky.social and the study team! www.nature.com/articles/s41...

Feasibility, acceptability and clinical outcomes of the BabyScreen+ genomic newborn screening study - Nature Medicine

The BabyScreen+ study offered genomic screening to 1,000 newborns in Australia, and showed that the approach is feasible and positively received by families, leading to molecular diagnoses in 1.6% of babies.

nature.com

Ilias Goranitis@iliasgoranitis.bsky.social · last yr.

Help us develop a roadmap for stakeholders to consider when integrating #healtheconomics alongside #genomics to inform decision-making. Please share your local perspectives on challenges & opportunities of evaluating and implementing genomics q.surveys.unimelb.edu.au/jfe/form/SV_...

Qualtrics Survey | Qualtrics Experience Management

The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.

q.surveys.unimelb.edu.au

Ilias Goranitis@iliasgoranitis.bsky.social · last yr.

Wonderful to see our paper on the #Value and #Implementation of #Genomic_Newborn_Screening published in @ajhgnews.bsky.social #BabyScreen+ #HealthEconomics #DCE

The American Journal of Human Genetics@ajhgnews.bsky.social · last yr.

📣New today! 📄Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia 🧑‍🤝‍🧑 @iliasgoranitis.bsky.social @zornitza.bsky.social & co

Zornitza Stark@zornitza.bsky.social · last yr.

What does the Australian public think about the value and implementation of genomic NBS? 🧬👶⚖️ @ajhgnews.bsky.social @iliasgoranitis.bsky.social @stephaniebest.bsky.social @genomeseb.bsky.social @genetic-fi.bsky.social #raredisease #genomics #healtheconomics www.sciencedirect.com/science/arti...

Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia

Integrating genomic sequencing into newborn screening (NBS) has transformative potential for the identification and management of genetic conditions. …

sciencedirect.com

Ilias Goranitis@iliasgoranitis.bsky.social · last yr.

A must-read: The Cost-Effectiveness of #Genomic_Medicine in #Cancer Control: A Systematic Literature Review link.springer.com/article/10.1... Grateful to the @who.int and Cancer Australia for their support.

The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review - Applied Health Economics and Health Policy

Background and Objective Genomic medicine offers an unprecedented opportunity to improve cancer outcomes through prevention, early detection and precision therapy. Health policy makers worldwide are d...

link.springer.com

Zornitza Stark@zornitza.bsky.social · last yr.

As @ausgenomics.bsky.social comes to an end: what have we learned? 🇦🇺🧬 @naturemedicine.bsky.social 👉 rdcu.be/eeuAN Change is hard! Key for success: working across disciplines; jurisdictions; and all leadership levels🏆 @stephaniebest.bsky.social @iliasgoranitis.bsky.social @andrewmallett8.bsky.social

Using implementation science to navigate the complexity of integrating genomics into healthcare

Nature Medicine - Australian Genomics led a country-level, longitudinal project to deliver and evaluate the impact of genomics in routine healthcare.

rdcu.be

Zornitza Stark@zornitza.bsky.social · last yr.

What happens when #genomic testing is funded?🧬 👉 rdcu.be/d8MSL Last 10yrs 🇦🇺: Many tests approved as evidence grows ✅ BUT testing volumes low AND inequitable access Budget impact of #genomics minor: AU$3Mpa or <0.01% of all health expenditure 💰 @ausgenomics.bsky.social @iliasgoranitis.bsky.social

Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023

European Journal of Human Genetics - Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023

rdcu.be

Ilias Goranitis@iliasgoranitis.bsky.social · last yr.

New paper in the European Journal of Human Genetics: Utilisation of subsidised genetic and genomic testing in Australia during 2014–2023 www.nature.com/articles/s41...

Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023 - European Journal of Human Genetics

European Journal of Human Genetics - Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023

nature.com

Zornitza Stark@zornitza.bsky.social · 2y ago

How do we measure the value of #genomics for #policy decisions? Check out our new GUV scale! 👉 www.valueinhealthjournal.com/article/S109... 👏 great collaboration @iliasgoranitis.bsky.social @andrewmallett8.bsky.social @stephaniebest.bsky.social @zoefehlberg.bsky.social @ausgenomics.bsky.social

A Standardized Measurement and Valuation Scale of Genomic Utility for Policy Decisions: The GUV Scale

The multifaceted ways in which genomics can be valuable to clinicians, patients, families, and society are important for informing prioritization decisions by policy makers. This study aims to develop...

valueinhealthjournal.com

Ilias Goranitis@iliasgoranitis.bsky.social · 2y ago

Honoured to receive a Dame Kate Campbell Fellowship and join excellent colleagues in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne who have inspired me with their work over the years!